Urothelial bladder cancer (UBC), the most common form of bladder cancer, is the sixth most common cancer in the U.S. About 85,000 people are diagnosed in the U.S. each year, but the good news is that treatments for UBC are getting more advanced and more effective.Immunotherapy is a type of treatment that uses the body’s own immune system to attack cancer cells. The Food and Drug Administration (FDA) approved the first immunotherapy treatment for UBC in 1990. And since then several more have been approved.Here’s everything you need to know about how immunotherapy works with the body to fight ca...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free
